Progression from Follicular thyroid cells to papillary thyroid cancer (PTC) or follicular thyroid cancer (FTC) is marked by mutations activating the MAPK- or PI3K-AKT signalling pathways, illustrated by the arrows. This evidence concerns the gene PIK3CA and thyroid cancer, nonmedullary, 2.